Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
2022-003382-38: Is Cerebrolysin efficient in neurorecovery after moderate-severe traumatic brain injury? Este Cerebrolysin eficient in neurorecuperare după traumatism cerebral moderat-sever?

Ongoing
3
440
Europe
Cerebrolysin, N07XXN3, Solution for injection/infusion, Cerebrolysin
FSNANO05012022, Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii
Moderate-severe traumatic brain injury Traumatism cerebral moderat-sever, Brain injury Traumatism cerebral, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT04904341: Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.

Recruiting
3
50
Europe
Cerebrolysin
Military Institute of Medicine, Poland, Brainomix Limited
Stroke, Ischemic, Stroke, Acute, Stroke Sequelae
12/23
12/24
NCT06052787: Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU

Recruiting
3
150
RoW
Cerebrolysin, amantadine sulfate, PK-MERZ
Ain Shams University
Traumatic Brain Injury
03/25
09/25
NCT05124353: Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Recruiting
2/3
100
Europe
Cerebrolysin, neuroprotective treatment
Pomeranian Medical University Szczecin
Stroke, Acute, Ischemic
04/23
04/23

Download Options